Evidence map›Paper›PMID 29992695›Full record

ArticleDrug and alcohol review2018

Differences in patterns of cannabis use among youth: Prevalence, perceptions of harm and driving under the influence in the USA where non-medical cannabis markets have been established, proposed and prohibited.

Elle Wadsworth, David Hammond

Abstract read
In one paragraph

Article in Drug and alcohol review, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Cannabis use as a moderator of cognitive behavioral therapy for insomnia.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elle WadsworthSchool of Public Health and Health Systems, University of Waterloo, Waterloo, Canada.ORCID 0000-0003-0797-8493
David HammondSchool of Public Health and Health Systems, University of Waterloo, Waterloo, Canada.

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEVY, DAVID THEODORE · 2016 to 2025
$25.3M
Canadian Institutes of Health Research (CIHR)CIHR-Public Health Agency of Canada Applied Chair in Public Health (Hammond)NCI NIH HHS P01 CA200512US National Institutes of Health 1P01CA200512-01Vanier Canada Graduate Scholarship
6 · The paper itself

Abstract

INTRODUCTION AND

aimsCannabis use is the most widely used illicit substance in the USA. Currently, over half of US jurisdictions have legalised medical cannabis and nine US jurisdictions (and Washington DC) have legalised non-medical cannabis. Comparisons across jurisdictions can help to evaluate the impact of these policies. The current study examined patterns of cannabis use among youth in three categories: (i) states that have legalised non-medical cannabis with established markets; (ii) jurisdictions that recently legalised non-medical cannabis without established markets; and (iii) all other jurisdictions where non-medical cannabis is prohibited. DESIGN AND

methodsData come from an online survey conducted among 4097 US youth aged 16-19 recruited through a commercial panel in July/August 2017. Regression models were fitted to examine differences between regulatory categories for cannabis consumption, perceived access to cannabis, modes of use, perceptions of harm and cannabis-impaired driving. All estimates represent weighted data.

resultsStates that had legalised non-medical cannabis had higher prevalence, easier access and lower driving rates than non-legal states. There were few differences between states with established non-medical cannabis markets and those that had recently legalised. DISCUSSION AND

conclusionsCannabis use among youth was higher in states that have legalised non-medical cannabis, regardless of how long the policy had been implemented or whether markets had been established. This suggests that differences between states with and without legal non-medical cannabis may partly be due to longer-term patterns established prior and highlights the importance of longitudinal evidence to evaluate the impact of cannabis policies.

Indexed as

PerceptionSurveys and QuestionnairesAdolescentCannabisCommerceDriving Under the InfluenceFemaleHarm ReductionHumansMaleMarijuana SmokingMedical MarijuanaPrevalenceSelf ReportUnited StatesYoung AdultMedical Marijuanacannabisdrug regulationslegal statusmarijuanayouth

Identifiers

PMID29992695
PMCPMC6215732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.